Case number 2018-1017
Gilead Sciences, Inc. v. Merck & Co., Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 13, 2018 | 29 | Mandate issued to the United States District Court for the Northern District of California. Service as of this date by the Clerk of Court. [542347] [JAB] [Entered: 08/13/2018 10:43 AM] (1) |
| Jul 6, 2018 | 28 | ORDER filed. The stay is lifted.; The motion for summary affirmance [27] is granted.; Each side shall bear its own costs. Service: 07/06/2018 by clerk. [533992] [NL] [Entered: 07/06/2018 10:22 AM] (2) |
| May 9, 2018 | 27 | Letter from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. re: Disposition of Appeal. Service: 05/09/2018 by email. [520380] [18-1017] [Jeffrey Lamken] [Entered: 05/09/2018 01:28 PM] (4) |
| Dec 20, 2017 | 26 | ORDER filed. The motion [25] is granted to the extent that the briefing schedule is stayed. Within 14 days of this court's disposition of Appeal Nos. 2016-2302, -2615, the parties are directed to inform this court as to how they believe this appeal should proceed. Service: 12/20/2017 by clerk. [484172] [LMS] [Entered: 12/20/2017 11:37 AM] (2) |
| Nov 21, 2017 | 25 | MOTION of Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. to stay appeal. Any response is due within 10 days of service, to extend the time to 02/02/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 11/21/2017 by email. [477447] [Jeffrey Lamken] [Entered: 11/21/2017 01:58 PM] (15) |
| Oct 31, 2017 | 23 | Entry of appearance for E. Joshua Rosenkranz as of counsel for Appellee Gilead Sciences, Inc.. Service: 10/31/2017 by email. [471863] [E. Rosenkranz] [Entered: 10/31/2017 11:33 AM] (1) |
| Oct 31, 2017 | 24 | Entry of appearance for Edmund Hirschfeld as of counsel for Appellee Gilead Sciences, Inc.. Service: 10/31/2017 by email. [471865] [Edmund Hirschfeld] [Entered: 10/31/2017 11:36 AM] (1) |
| Oct 20, 2017 | 2 | Entry of appearance for Jeffrey A. Lamken as principal counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469329] [Jeffrey Lamken] [Entered: 10/20/2017 10:11 AM] (2) |
| Oct 20, 2017 | 3 | Certificate of Interest for the Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469332] [Jeffrey Lamken] [Entered: 10/20/2017 10:12 AM] (4) |
| Oct 20, 2017 | 4 | Docketing Statement for the Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469333] [Jeffrey Lamken] [Entered: 10/20/2017 10:13 AM] (3) |
| Oct 20, 2017 | 5 | Entry of appearance for Michael G. Pattillo, Jr. as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469337] [Michael Pattillo] [Entered: 10/20/2017 10:16 AM] (2) |
| Oct 20, 2017 | 6 | Entry of appearance for Sarah J. Newman as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469339] [Sarah Newman] [Entered: 10/20/2017 10:18 AM] (2) |
| Oct 20, 2017 | 7 | Entry of appearance for James A. Barta as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469340] [James Barta] [Entered: 10/20/2017 10:20 AM] (2) |
| Oct 20, 2017 | 8 | Entry of appearance for Sara E. Margolis as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469341] [Sara Margolis] [Entered: 10/20/2017 10:22 AM] (2) |
| Oct 20, 2017 | 9 | Entry of appearance for Stephen S Rabinowitz as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469352] [Stephen Rabinowitz] [Entered: 10/20/2017 11:14 AM] (2) |
| Oct 20, 2017 | 10 | Entry of appearance for Mitchell Epner as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469355] [Mitchell Epner] [Entered: 10/20/2017 11:20 AM] (2) |
| Oct 20, 2017 | 11 | Entry of appearance for Juanita R. Brooks as principal counsel for Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469505] [Juanita Brooks] [Entered: 10/20/2017 02:24 PM] (3) |
| Oct 20, 2017 | 12 | Entry of appearance for Elizabeth M. Flanagan as of counsel for Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469506] [Elizabeth Flanagan] [Entered: 10/20/2017 02:27 PM] (2) |
| Oct 20, 2017 | 13 | Docketing Statement for the Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469507] [Elizabeth Flanagan] [Entered: 10/20/2017 02:30 PM] (4) |
| Oct 20, 2017 | 14 | Certificate of Interest for the Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469509] [Elizabeth Flanagan] [Entered: 10/20/2017 02:34 PM] (3) |
| Oct 20, 2017 | 15 | Entry of appearance for Jonathan E. Singer as of counsel for Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469510] [Jonathan Singer] [Entered: 10/20/2017 02:36 PM] (2) |
| Oct 20, 2017 | 16 | Entry of appearance for Robert M. Oakes as of counsel for Appellee Gilead Sciences, Inc.. Service: 01/20/2017 by email. [469511] [Robert Oakes] [Entered: 10/20/2017 02:37 PM] (2) |
| Oct 20, 2017 | 17 | Entry of appearance for Deanna J. Reichel as of counsel for Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469513] [Deanna Reichel] [Entered: 10/20/2017 02:42 PM] (2) |
| Oct 20, 2017 | 18 | Entry of appearance for Craig E. Countryman as of counsel for Appellee Gilead Sciences, Inc.. Service: 10/20/2017 by email. [469515] [Craig Countryman] [Entered: 10/20/2017 02:48 PM] (2) |
| Oct 20, 2017 | 19 | Entry of appearance for Bruce Genderson as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469544] [Jessica Ryen] [Entered: 10/20/2017 03:52 PM] (2) |
| Oct 20, 2017 | 20 | Entry of appearance for Jessamyn S. Berniker as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469545] [Jessica Ryen] [Entered: 10/20/2017 03:56 PM] (2) |
| Oct 20, 2017 | 21 | Entry of appearance for Stanley E. Fisher as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469547] [Jessica Ryen] [Entered: 10/20/2017 03:58 PM] (2) |
| Oct 20, 2017 | 22 | Entry of appearance for Jessica Palmer Ryen as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 10/20/2017 by email. [469548] [Jessica Ryen] [Entered: 10/20/2017 04:00 PM] (2) |
| Oct 6, 2017 | 1 | Appeal docketed. Received: 10/05/2017. [466004]Entry of Appearance due 10/20/2017. Certificate of Interest due 10/20/2017. Docketing Statement due 10/20/2017. Appellants' brief due 12/05/2017. [MJL] [Entered: 10/06/2017 09:25 AM] (83) |
